foxo4 dri peptide senolytic 2023 2024 study Frontiers Development of a novel senolytic
Description
MDMA and LSD"
Often discussed in the context of metabolism, its gaining traction in functional medicine for its role in weight management and metabolic support, akin to well-known peptides like semaglutide and tirzepatide.[4][5] Unlike these GLP-1 agonists, which primarily mimic hormones to regulate appetite, 5-Amino-1MQ targets enzymatic pathways directly, offering a complementary mechanism that doesn't rely on hormonal simulation
10.1073/pnas.2106504118 Proc
Can be used with any medication or supplement
